Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort
-
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
-
AstraZeneca to collaborate with Inserm in Type 2 Diabetes and Chronic Kidney Disease studies
-
AstraZeneca to collaborate with the University of Michigan to advance treatments for Chronic Kidney Disease
-
AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
-
AstraZeneca reveals findings of archaeological dig as build gets underway at Cambridge Biomedical Campus
-
New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin compared with sitagliptin
-
AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformin for the treatment of type 2 diabetes
-
AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the American Diabetes Association 75th Scientific Sessions
-
AstraZeneca updates on immuno-oncology combinations development programme at the 2015 ASCO Annual Meeting
Latest articles and press releases
All of our latest press releases and articles are available to explore
